Cellectar Biosciences Inc. (NASDAQ:CLRB)
Old Forum Content for CLRB
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.- woodman: #Biotechs I'm focusing on (mostly for at least Q1/H1 2024) (in no particular order): $ARDX (I plan to contnue holding this through full year 2024) $EFTR $XFOR $VKTX $MREO (good buyout potential) $PDSB $INZY $CLRB (mainly for 1/8 data to be presented at JPM Healthcare Conf). Possibly some others as well such as $ORIC (I've lost focus on it and need to reacquaint myself) and $ACAD.
- woodman: $CLRB - added ahead of JPM healthcare conference the week of 1/8 where it will present Phase 3 data for its WM treatment. https://www.cellectar.com/news-media/press-releases/detail/315/cellectar-to-release-top-line-data-from-wm-pivotal-trial
- woodman: $CLRB on the rise into JPM Healthcare Conf. occuring week of 1/8/24. I have a position in this (bought ~$2.50). Why would it be presenting if the data aren't good? Lots of positives in this one reading other tea leaves as well. Could be a big mover on good data, but there never are guarantees. A bit of a lotto ticket. https://www.cellectar.com/news-media/press-releases/detail/315/cellectar-to-release-top-line-data-from-wm-pivotal-trial
- woodman: $CLRB - At the JPM HC conference on 1/8, this one will be presenting open label late stage pivotal data for its drug to treat Waldenstrom macroglobulinemia (WM). The question is why would this present at a prestigious health care conference if the data were bad? It's a gamble, but I bought some. Small position, though I may add to it in the interim. https://www.cellectar.com/product-pipeline
Stock Price | $3.98 |
Change | 9.49% |
Volume | 1,765,810 |
Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.
Request Video of CLRBAlready a member? Sign in here.
Past Month
Leading Peers
-
$11.94 330.09%
-
$14.14 197.10%
-
$9.49 173.74%
Past Month
Lagging Peers
-
$22.90 -51.95%
-
$5.14 -44.74%
-
$7.59 -41.55%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!